Gossamer Bio, Inc. (GOSS)
Gossamer Bio Market Cap : 79.80M for May 15, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Vanda Pharmaceuticals, Inc. | 377.65M |
| Gilead Sciences, Inc. | 160.88B |
| Ironwood Pharmaceuticals, Inc. | 589.32M |
| REGENXBIO, Inc. | 295.71M |
| CytomX Therapeutics, Inc. | 785.91M |
Market Cap Related Metrics
| PS Ratio | 1.594 |
| PEG Ratio | -0.0024 |
| Price | 0.34 |
| Earnings Yield | -173.1% |
| PEGY Ratio | -0.0024 |